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Kinetics of Lung Lesion Development and Pro-Inflammatory Cytokine
Response in Pigs With Vaccine-Associated Enhanced Respiratory Disease
Induced by Challenge With Pandemic (2009) A/H1N1 Influenza Virus
Abstract
The objective of this report was to characterize the enhanced clinical disease and lung lesions observed in pigs
vaccinated with inactivated H1N2 swine δ-cluster influenza A virus and challenged with pandemic 2009 A/
H1N1 human influenza virus. Eighty-four, 6-week-old, cross-bred pigs were randomly allocated into 3 groups
of 28 pigs to represent vaccinated/challenged (V/C), non-vaccinated/challenged (NV/C), and non-
vaccinated/non-challenged (NV/NC) control groups. Pigs were intratracheally inoculated with pH1N1and
euthanized at 1, 2, 5, and 21 days post inoculation (dpi). Macroscopically, V/C pigs demonstrated greater
percentages of pneumonia compared to NV/C pigs. Histologically, V/C pigs demonstrated severe
bronchointerstitial pneumonia with necrotizing bronchiolitis accompanied by interlobular and alveolar
edema and hemorrhage at 1 and 2 dpi. The magnitude of peribronchiolar lymphocytic cuffing was greater in
V/C pigs by 5 dpi. Microscopic lung lesion scores were significantly higher in the V/C pigs at 2 and 5 dpi
compared to NV/C and NV/NC pigs. Elevated TNF-α, IL-1β, IL-6, and IL-8 were detected in
bronchoalveolar lavage fluid at all time points in V/C pigs compared to NV/C pigs. These data suggest H1
inactivated vaccines followed by heterologous challenge resulted in potentiated clinical signs and enhanced
pulmonary lesions and correlated with an elevated proinflammatory cytokine response in the lung. The lung
alterations and host immune response are consistent with the vaccine-associated enhanced respiratory disease
(VAERD) clinical outcome observed reproducibly in this swine model.
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Abstract
The objective of this report was to characterize the enhanced clinical disease and lung lesions observed in pigs vaccinated with
inactivated H1N2 swine d-cluster influenza A virus and challenged with pandemic 2009 A/H1N1 human influenza virus. Eighty-
four, 6-week-old, cross-bred pigs were randomly allocated into 3 groups of 28 pigs to represent vaccinated/challenged (V/C),
non-vaccinated/challenged (NV/C), and non-vaccinated/non-challenged (NV/NC) control groups. Pigs were intratracheally inocu-
lated with pH1N1and euthanized at 1, 2, 5, and 21 days post inoculation (dpi). Macroscopically, V/C pigs demonstrated greater
percentages of pneumonia compared to NV/C pigs. Histologically, V/C pigs demonstrated severe bronchointerstitial pneumonia
with necrotizing bronchiolitis accompanied by interlobular and alveolar edema and hemorrhage at 1 and 2 dpi. The magnitude of
peribronchiolar lymphocytic cuffing was greater in V/C pigs by 5 dpi. Microscopic lung lesion scores were significantly higher in the
V/C pigs at 2 and 5 dpi compared to NV/C and NV/NC pigs. Elevated TNF-a, IL-1b, IL-6, and IL-8 were detected in bronchoal-
veolar lavage fluid at all time points in V/C pigs compared to NV/C pigs. These data suggest H1 inactivated vaccines followed by
heterologous challenge resulted in potentiated clinical signs and enhanced pulmonary lesions and correlated with an elevated
proinflammatory cytokine response in the lung. The lung alterations and host immune response are consistent with the
vaccine-associated enhanced respiratory disease (VAERD) clinical outcome observed reproducibly in this swine model.
Keywords
swine, influenza A virus, pandemic H1N1, vaccine, enhanced pneumonia
Influenza A virus (IAV) is the cause of an acute respiratory
disease in swine characterized by anorexia, fever, dyspnea,
coughing, and nasal discharge.30 Influenza A virus is a member
of the Orthomyxoviridae family, with segmented, negative
sense RNA genomes that permit the generation of novel, anti-
genically distinct viruses. The swine respiratory tract contains
receptors for both avian and human IAVs, which may increase
susceptibility to interspecies transmission and facilitate
genetic diversity through reassortment.13 Influenza infection
in naive swine is typically associated with high morbidity and
low mortality, with some variation in virulence between
strains. In the Northcentral United States, disease incidence
peaks during the fall; however, epizootics may occur that do
not follow this once typical seasonality.1
The stability of classical H1N1 (cH1N1) IAV in North
American swine persisted for over 70 years, ending in 1998
with the introduction of the triple reassortant H3N2 that con-
tained genes of human-, avian-, and swine-virus lineages.47,48
Influenza A viruses that are currently endemic in North
American swine are all triple reassortants that contain the triple
reassortant internal gene (TRIG) cassette, which consists of
human-IAV lineage polymerase basic 1 (PB1), avian-IAV line-
age polymerase basic 2 (PB2), polymerase acidic (PA) and
swine-IAV lineage nucleoprotein (NP), matrix (M), and
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nonstructural (NS) genes.20,41 The apparent ability of the TRIG
cassette to exchange gene segments for the surface glycopro-
teins hemagglutinin (HA) and neuraminidase (NA) has further
increased the generation of reassortant IAVs with marked
antigenic diversity.40 In addition, drift variants within the
three major subtypes, H1N1, H1N2, and H3N2, have also
emerged.3,19,24,29,40,44
Currently, four H1 phylogenetic clusters, a, b, g, and d, are
endemic in US swine, acquired through interspecies transmis-
sion, reassortment events, and antigenic drift.40,42 Unlike IAV
variants isolated before 1998, which demonstrated more con-
sistent cross-reactivity in the hemagglutination inhibition
(HI) assay, contemporary viruses exhibit limited HI cross-
reactivity between different clusters, in spite of the similarity
in subtype.39,40 Additionally, 2 subclusters have emerged within
the H1 d-cluster from two apparently independent introductions
of a human seasonal HA into IAVs in swine and have been
designated d-1 and d-2.18 Collectively, the emergence of the
pandemic 2009 H1N1 virus, the introduction of human seasonal
influenza viruses in swine, and the generation of antigenic var-
iants within a subtype with less consistent serological cross-
reactivity provides substantial evidence of the increasing hetero-
geneity among IAVs in swine.
The use of inactivated IAV vaccines in swine is common in
the US, and such vaccines effectively reduce clinical disease and
lesion induction by homologous viruses,38 although protection
against heterologous infection has been inconsistent.2,21,36,38
However, inactivated influenza vaccines also have been impli-
cated in vaccine-associated enhanced respiratory disease
(VAERD) in swine.8,12,16,38 Recently, a vaccination-heterolo-
gous-challenge model was described in which naı¨ve pigs vacci-
nated with an inactivated, adjuvanted H1N2 swine d-cluster IAV
and challenged with pandemic 2009 A/H1N1 human influenza
virus demonstrated severe clinical disease, enhanced lung conso-
lidation, and potentiated microscopic lesions compared to non-
vaccinated and challenged pigs.8 The vaccine did not prevent
infection, and hemagglutination inhibition and serum neutraliz-
ing (SN) antibodies did not cross-react with the challenge virus.
The inactivated vaccine was decidedly associated with VAERD,
although the mechanism remains unclear at this time. Due to the
emergence of novel IAVs in swine and a complex number of
cocirculating subtypes and variants, VAERD could occur in
field situations where pigs may be vaccinated with farm-
specific vaccines and then subsequently break with antigeni-
cally diverse IAVs. The vaccine-associated enhancement
of disease phenomenon is not exclusive to swine and inacti-
vated IAV vaccines. Nonprotective, low avidity antibodies
elicited by respiratory syncytial virus and measles formalin-
inactivated vaccines have also been implicated in causing
enhanced respiratory disease in human infants.4,26
The objective of this study was to characterize the enhanced
macroscopic and microscopic lung lesions in pigs administered
an inactivated d-cluster H1N2 IAV and challenged with pan-
demic 2009 A/H1N1 (pH1N1) as compared to nonvacci-
nated/challenged pigs using a previously described model.8
Macroscopic and microscopic lung lesions, virus distribution
in the lungs, and local inflammatory responses were evaluated
at 1, 2, 5, and 21 days post inoculation (dpi) to elucidate the
onset and development of VAERD in pigs challenged with
pH1N1 IAV.
Materials and Methods
Experimental Design
Eighty-four, 3-week-old cross-bred pigs were obtained from a
herd free of IAV and porcine reproductive and respiratory syn-
drome virus (PRRSV) and treated with ceftiofur (Pfizer Animal
Health, New York, NY) according to label directions to reduce
respiratory bacterial pathogens prior to the start of the study.
Pigs were housed in biosafety level 2 (BSL2) containment dur-
ing the vaccine phase of the study. Fifty-six pigs were trans-
ferred to ABSL3 containment 1 week prior to challenge for
the remainder of the experiment. Pigs were cared for in compli-
ance with the Institutional Animal Care and Use Committee of
the National Animal Disease Center. The experimental design
is described in Table 1.
Influenza A virus vaccine was prepared with a d-1 cluster A/
Sw/MN/02011/2008 H1N2 (MN08) at approximately 32 HA
units or 105.7 50% tissue culture infectious dose (TCID50) that
was inactivated by ultraviolet irradiation and mixed with an
emulsified oil-in-water adjuvant (Emulsigen1-D, MVP Tech-
nologies, Omaha, NE) at a v:v ratio of 4:1 virus to adjuvant.
Pigs were vaccinated with 2 ml by the intramuscular route at
approximately 6 and 9 weeks of age, and challenged at
13 weeks of age. For viral challenge, pigs were inoculated
intratracheally with 2 ml of 1  105 TCID50 of pandemic
A/CA/04/2009 H1N1 (pH1N1) propagated in Madin-Darby
Canine Kidney (MDCK) cells, as previously described.42 Pigs
were observed daily for signs of clinical disease, and rectal
temperatures were taken on –1, 0, 1, 2, 3, 4, and 5 days dpi.
Nasal swabs (Fisherbrand Dacron swabs, Fisher Scientific,
Pittsburg, PA) were taken on 0, 1, 2, 3, 5, and 21 dpi to eval-
uate nasal virus shedding as previously described.39 After
serum collection by venipuncture, pigs were humanely eutha-
nized with a lethal dose of pentobarbital (Sleepaway, Fort
Dodge Animal Health, Fort Dodge, IA) on 1, 2, 5, or 21 dpi
to evaluate lesions, cytokine concentrations, and virus titers
in the lungs. Postmortem samples included bronchoalveolar
lavage fluid (BALF), lung, and trachea.
Table 1. Experimental Design
Necropsy N
Groupa Vaccine Challenge N 1 dpib 2 dpi 5 dpi 21 dpi
V/C MN08 pH1N1 28 8 8 8 4
NV/C None pH1N1 28 8 8 8 4
NV/NC None None 28 8 8 8 4
aGroups include vaccinated/challenged (V/C), non-vaccinated/challenged
(NV/C), non-vaccinated/non-challenged (NV/NC).
bDays post inoculation (dpi).
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Pathologic Examination of Lungs
At necropsy, lungs were removed and evaluated for the per-
centage of the lung affected with purple-red consolidation typ-
ical of IAV in swine. The percentage of the surface area
affected with pneumonia was visually estimated for each lung
lobe, and total percentage for the entire lung was calculated
based on weighted proportions of each lobe to the total lung vol-
ume.11 Tissue samples from the trachea and right middle or
affected lung lobe were fixed in 10% buffered formalin for his-
topathologic examination. Tissues were processed by routine
histopathologic procedures and slides stained with hematoxylin
and eosin. Microscopic lesions were evaluated by a veterinary
pathologist blinded to treatment groups. Individual scores were
assigned to each of 4 parameters to adequately reflect the contri-
bution of each lesion associated with VAERD: bronchial and
bronchiolar epithelial necrosis or proliferation, suppurative bron-
chitis or bronchiolitis, peribronchiolar lymphocytic cuffing, and
alveolar septal thickening with inflammatory cells (interstitial
pneumonia). The first 2 scores focused on the intrapulmonary
airways: (1) percentage of bronchi and bronchioles affected with
epithelial lesions (necrotizing or proliferative bronchitis and
bronchiolitis) and (2) percentage of bronchi and bronchioles that
contained purulent exudate (suppurative bronchitis or bronchio-
litis). Two additional lung lesion scores were based on the fol-
lowing: (3) magnitude of peribronchiolar lymphocytic cuffing
and (4) presence and severity of alveolar septal inflammation
(interstitial pneumonia). A composite score was computed using
the sum of the 4 individual scores. The average group composite
score was used for statistical analysis. Scoring parameters for
lung and trachea are described in Table 2.
Influenza virus Type A-specific antigen was detected in lung
and trachea using a previously described immunohistochemical
(IHC) method with minor modification.38,43 Modifications
include treating tissue sections in 0.05% protease for 2 min.
Influenza A virus-specific monoclonal antibody (MAb) HB65
(ATCC, Manassas, VA) was applied at 1:100 dilution. Bound
MAbs were stained with peroxidase-labeled anti-mouse IgG fol-
lowed by chromogen using the DAKO LSAB2-HRP Detection
System (DAKO, Carpinteria, CA) according to the manufactur-
er’s instructions. Antigen detection in lung was given 2 scores:
(1) airway epithelial signals and (2) alveolar septa/lumen signals.
Both scores were based only on affected lobules. IHC slides
were evaluated by a veterinary pathologist blinded to treatment
groups. Scoring parameters are described in Table 2.
Diagnostic Microbiology
All pigs were screened for antibody against influenza A NP by
ELISA (MultiS ELISA, IDEXX, Westbrook, ME) according to
the manufacturer’s recommendation upon arrival to ensure
absence of existing immunity from prior exposure or maternal
derived antibody and at 0 dpi to detect vaccine-induced NP
antibodies. BALF samples from 1, 2, 5, and 21 dpi were cul-
tured for aerobic bacteria on blood agar and Casmin (NAD
enriched) plates. Polymerase chain reaction (PCR) assays for
porcine circovirus type 2 (PCV2),25 Mycoplasma hyopneumo-
niae,32 and PRRSV also were conducted on nucleic acid
extracts from BALF collected at each necropsy.
Viral Replication and Shedding
Nasal swabs and BALF were processed as previously
described.38,39 MDCK-inoculated monolayers were evaluated
for cytopathic effect (CPE) between 48 and 72 h postinfection
and subsequently fixed with 4% phosphate-buffered formalin
Table 2. Scoring Parameters Used for Evaluation of Hematoxylin/Eosin (H&E) Microscopic Lesions and Immunohistochemistry (IHC) Signals in
Lung and Trachea (Scores Range From 0 to 3)
Numerical score
Tissue Lesion 0 1 1.5 2 2.5 3
Lung H&E Necrotizing bronchitis/bronchiolitis None < 5%a 5% to 25% 26% to 50% 51% to 75% > 75%
Suppurative bronchitis/bronchiolitis None < 5%b 5% to 25% 26% to 50% 51% to 75% > 75%
Peribronchiolar lymphocytic cuffing None Mild Moderate Severe
Light inflammationc Prominent Marked
Alveolar septal inflammation None Mild Moderate Severe
Focal inflammationc Locally extensive Diffuse
Trachea H&E Epithelial attenuation/necrosis None Focal Diffuse Diffuse
Cilia present Focal loss of cilia Cilia absent
Lung IHC Airway epithelium signal None Minimal Moderate Abundant
Occasional signalsc Scattered signals Scattered signals
Alveoli lumen/septum signal None Minimal Moderate Abundant
Focal signalsc Multifocal signals Diffuse signals
Trachea IHC Epithelial signals None Minimal Moderate Abundant
Focal signalsc Multifocal signals Diffuse signals
aPercentage of bronchi and bronchioles with epithelial necrosis in section examined.
bPercentage of bronchi and bronchioles with suppurative inflammation in section examined.
cScores based on mild, moderate, severe inflammation in H&E sections or minimal, moderate, abundant signals in IHC sections.
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and stained using immunocytochemistry with an anti-influenza
A nucleoprotein monoclonal antibody as previously described.15
A TCID50 titer was calculated for each sample using the method
of Reed and Muench.28
Antibody Detection Assays
Hemagglutination inhibition assays were conducted as previ-
ously described.38 The HI assays were performed with MN08
or pH1N1 virus as antigen and turkey red blood cells (RBCs)
as indicators using standard techniques.45 Reciprocal titers were
divided by 10 and log2 transformed, analyzed, and reported as
the geometric mean.
Enzyme-linked immunosorbent assays (ELISA) to detect
total IgG and IgA antibodies against whole virus preparations
of MN08 and pH1N1 present in serum were performed as previ-
ously described.38 Independent assays were conducted using
concentrated MN08 or pH1N1 as ELISA antigen. The optical
density (OD) was measured at 405 nm wavelength with an auto-
mated ELISA reader. Antibody levels were reported as the mean
OD and the mean OD of each treatment group were compared.
For the SN assay, sera were heat inactivated at 56C for
30 min, then 2-fold serially diluted from 1:10 to 1:20, 480 in
96-well plates, using 50 ml serum diluted in serum-free MEM
supplemented with L-1-tosylamido-2-phenylethyl chloro-
methyl ketone (TPCK) trypsin and antibiotics. Fifty microliters
of SIV diluted to 103.3 TCID50 /ml was added to each dilution
and incubated at 37C for 1 hr. Post incubation, 100 ml of the
serum and virus mixture was added to each well of confluent
MDCK cells prepared in 96-well plates 48 hours in advance and
washed twice in sterile PBS. Plates were incubated for 48 hours
or until the presence of cytopathic effect (CPE). Presence of
influenza virus was verified by immunocytochemistry for all
plates, and titers were recorded as the highest dilution negative
for virus or CPE. Reciprocal titers were log2 transformed, ana-
lyzed, and reported as the geometric mean.
Cytokine Assays
A 5 ml aliquot of BALF was centrifuged at 400  g for 15 min
at 4C to pellet cellular debris. The cell-free BALF was stored
at –80 C. Cytokine concentrations in BALF were determined
by multiplex ELISA performed according to the manufactur-
er’s recommendations (SearchLight, Aushon Biosystems). The
average of duplicate wells for each sample was used for statis-
tical analysis.
Statistical Analysis
Macroscopic pneumonia scores, microscopic pneumonia
scores, log10 transformed BALF and nasal swab virus titers,
log2 transformations of HI and SN reciprocal titers, mean OD
ELISA reading, and cytokine data were analyzed using analysis
of variance (ANOVA) with a P value  .05 considered signif-
icant (JMP, SAS Institute, Cary, NC; GraphPad Prism Version
5.00, San Diego, CA). Response variables shown to have a
significant effect by treatment group were subjected to pairwise
comparisons using the Tukey-Kramer test. Rectal temperature
data were analyzed using a mixed linear model for repeated
measures. Linear combinations of the least squares means
estimates were used in a priori contrasts after testing for a
significant (P < .05) treatment group effect of vaccination
status. Comparisons were made between each group at each
time-point using a 5% level of significance (P < .05) to assess
statistical differences.
Results
Clinical Disease
Mild lethargy was observed at 1 dpi in the non-vaccinated/
challenged (NV/C) pigs with activity returning to normal by
2 dpi. Coughing or dyspnea was not observed in the NV/C pigs.
In contrast, vaccinated/challenged (V/C) pigs were lethargic
and anorexic for 48 hours, and 20% of the V/C pigs exhibited
coughing and/or dyspnea until 3 dpi. Challenge with pH1N1
virus induced a significant (P  .05) febrile response in both
V/C and NV/C groups at 24 and 48 hours post infection com-
pared to non-vaccinated/non-challenged (NV/NC) pigs. This
initial febrile response in the challenged pigs subsided by 3 dpi.
However, a significantly different febrile response was not
detected between V/C and NV/C pigs on any sampling post
challenge. NV/NC pigs did not demonstrate clinical signs or
a febrile response during the trial.
Viral and Microbiological Assays
All pigs were free of IAV antibodies prior to the start of the
experiment. No PCV2, PRRSV, or M. hyopneumoniae nucleic
acid was detected in BALF in any pigs. Routine aerobic bacter-
ial cultures of BALF isolated Bordetella bronchiseptica from
one pig in the NV/C group. Bacteria were not isolated from the
lungs of any other pigs during the trial.
Macroscopic Pneumonia
Pigs challenged with pH1N1 displayed purple-colored, multi-
focal to coalescing consolidation of the cranioventral regions
of lung typical of IAV infection in swine. Lung lesions were
of variable extent in both challenge groups and were predomi-
nantly located in the left and right cranial and middle lung
lobes. Lesions were also observed in the cranial portion of the
diaphragmatic lobes in some of the V/C pigs but not in the
NV/C pigs. The V/C group had a significantly greater (P 
.001) percentage of lung consolidation compared to the
NV/C pigs at 1, 2, 5, and 21 dpi (Table 3). The average per-
centage of lung consolidation increased at each acute time
point in V/C pigs from approximately 10% at 1 dpi (Fig. 1)
to >20% at 5 dpi (Fig. 2). In the NV/C pigs, only slight
increases in percentage of lung consolidation were observed
between 1 dpi (Fig. 3) and 5 dpi (Fig. 4) and never exceeded
7%. Macroscopic lung lesions were absent or minimal in pigs
in the NV/NC group.
Gauger et al 903
 at IOWA STATE UNIV on October 30, 2015vet.sagepub.comDownloaded from 
Microscopic Pneumonia
The average composite microscopic lung lesion score was sig-
nificantly higher (P  .01) in the V/C pigs at 2 and 5 dpi com-
pared to NV/C pigs (Table 3). The average composite score
was also higher in the V/C pigs at 1 dpi compared to the NV/
C group, although a statistically significant difference was not
observed. Microscopic lesions were not evident in lung in the
NV/NC pigs at any time during the study.
NV/C pigs exhibited microscopic lung lesions consistent
with uncomplicated influenza virus infection, demonstrating
mild airway epithelial attenuation with concurrent suppurative
bronchitis and/or bronchiolitis and mild bronchointerstitial
pneumonia at 1 dpi (Fig. 5). Multifocal bronchi, bronchioles,
and alveolar lumina contained low to moderate numbers of
neutrophils and scattered macrophages. Necrotizing bronchio-
litis became more pronounced by 2 dpi, although suppurative
inflammation in bronchi, bronchioles, and particularly the
alveoli had almost completely subsided by this time. At 5 dpi,
NV/C pigs demonstrated necrotizing or proliferative bronchitis
and bronchiolitis with light, peribronchiolar lymphocytic cuff-
ing (Fig. 6). Multifocally, alveolar septa were expanded by
mild to moderate numbers of lymphocytes and macrophages.
In contrast to the mild microscopic lung lesions demon-
strated in the NV/C pigs, lung lesion profiles were notably
more widespread and severe in the V/C pigs with VAERD
occurring as rapidly as 1 dpi. Alveolar lumina were flooded
by large amounts of eosinophilic proteinaceous material
(edema) and hemorrhage (Fig. 7) that was not observed in the
NV/C group. Marked interlobular edema was also demon-
strated exclusively in the V/C pigs (Fig. 7), and an abundant,
suppurative inflammatory infiltrate was observed in a larger
percentage of bronchi and bronchioles in the VAERD-
affected pigs compared to the NV/C group. Alveolar lumina
bordering affected bronchioles and extending into adjacent
lobules were expanded or occluded by large numbers of neutro-
phils and scattered macrophages in V/C pigs (Fig. 8), contrast-
ing the mild suppurative inflammatory response in alveolar
lumina of NV/C pigs (Fig. 5). However, VAERD-affected pigs
demonstrated mild bronchi and bronchiolar epithelial necrosis
that was similar to the NV/C group at 1 dpi.
By 2 dpi, composite microscopic lesion scores increased in
the V/C group (Table 3) due to a moderate elevation in alveolar
septal mononuclear inflammation and abundant neutrophils,
macrophages, edema, and hemorrhage that persisted in alveolar
lumina of affected lobules (Fig. 9). Suppurative inflammation
present in the NV/C pigs at 1 dpi noticeably diminished by 2
dpi. Vaccinated/challenged pigs also demonstrated prominent
peribronchiolar lymphocytic cuffing in contrast to light peri-
bronchiolar cuffing observed in the NV/C group. Both chal-
lenge groups exhibited more severe epithelial necrosis of the
bronchioles and occasional bronchi at 2 dpi.
Microscopic lung lesion profiles were characterized by
increased lymphocytic inflammation in the V/C group at 5 dpi.
The alveolar luminal edema and neutrophils decreased or were
replaced by large numbers of alveolar macrophages, sloughed
pneumocytes, and cellular debris. Alveolar lumina were often
collapsed by marked, widespread alveolar septal thickening
by lymphocytes, macrophages, and type II pneumocyte hyper-
trophy and hyperplasia that was less prominent in the NV/C
pigs at 5 dpi. Only the VAERD-affected pigs demonstrated
broad peribronchiolar cuffs of densely packed lymphocytes
(Fig. 10). Large numbers of lymphocytes expanded the bronch-
iolar lamina propria, displacing the affected epithelium and
occasionally narrowing the bronchiolar lumen (Fig. 10). Neutro-
phils persisted in the lumen of a larger percentage of bronchi and
bronchioles in the V/C pigs (Fig. 10) compared to the NV/C
group, with occasional neutrophil exocytosis within bronchiolar
epithelium. Both challenge groups demonstrated similar levels
of bronchi and bronchiolar epithelial necrosis, which was often
replaced by proliferative, columnar epithelium by 5 dpi.
Microscopic Trachea Lesions
Average trachea lesion scores in the V/C group were signifi-
cantly higher (P  .001) at 1, 2, and 5 dpi compared to NV/
C pigs. Average trachea lesion scores for NV/C pigs were
0.16, 0.13, and 0.63 at 1, 2, and 5 dpi, respectively. NV/C pigs
had minimal to mild attenuation of the tracheal epithelium with
mild to moderate, multifocal, lymphocytic tracheitis at 1 and 2
dpi that became more pronounced at 5 dpi. In contrast, average
Table 3. Comparison of the Mean Percentage Lung Lesions (Purple-Red Consolidation) and Mean Microscopic Lesion Score (Necrotizing
Bronchiolitis, Suppurative Bronchiolitis/Bronchitis, Peribronchiolar Lymphocytic Cuffing, Alveolar Septal Thickening With Mononuclear
Inflammation) in Vaccinated/Challenged (V/C), Non-Vaccinated/Challenged (NV/C) and Non-Vaccinated/Non-Challenged (NV/NC) Pigs at
1, 2, 5, and 21 Days After pH1N1 Inoculation (dpi; Data Presented as the Mean Percentage Consolidation or Mean Composite Lesion Score
+ Standard Error of the Mean)
Group
Lung consolidationx Microscopic pneumonia scorey
1 dpi 2 dpi 5 dpi 21 dpi 1 dpi 2 dpi 5 dpi 21 dpi
V/C 10.7 + 1.5a
z 13.4 + 2.3a 21.4 + 3.1a 1.3 + 0.4a 7.5 + 0.4a 9.8 + 0.5a 10.3 + 0.9a 0.7 + 0.3a
NV/C 3.6 + 0.6b 4.1 + 0.7b 6.8 + 1.6b 0.1 + 0.1b 5.9 + 1.0a 5.3 + 1.1b 7.2 + 0.4b 0.7 + 0.2a
NV/NC 0.1 + 0.1c 0.1 + 0.1b 0.1 + 0.0b 0.1 + 0.1b 0.0 + 0.0b 0.0 + 0.0c 0.0 + 0.0c 0.0 + 0.0a
xPercentage consolidation calculated on a weighted average of each lung lobe.
yComposite scores range from 0 to 12 based on parameters described in Table 2.
zDifferent subscripts (a, b, c) indicate significantly different (P  .05) mean percentage consolidation or microscopic pneumonia scores within a column for each dpi.
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trachea lesion scores for V/C pigs were 1.41, 1.88, and
1.84 at 1, 2, and 5 dpi, respectively. Vaccinated/challenged pigs
demonstrated multifocal regions of trachea epithelial attenua-
tion with moderate lymphocytic and suppurative infiltrates at
1 dpi. At 2 and 5 dpi, tracheal lesions became more severe and
widespread to include locally extensive, lymphoplasmacytic
and necrosuppurative tracheitis with regional loss of cilia and
severe lymphoplasmacytic infiltration of tracheal submucosa
(Fig. 11). Occasionally, aggregates of neutrophils were appar-
ent in trachea epithelium in the V/C pigs. Lesions were simi-
larly minimal in both challenge groups at 21 dpi. Microscopic
lesions were not evident in trachea in the NV/NC pigs at any
time during the study.
Lung Immunohistochemistry
Influenza A virus antigen was detected by IHC as brown, gran-
ular, nuclear, and cytoplasmic signals in all pigs challenged
with pH1N1 at 1 dpi (Fig. 12). At 2 dpi, IAV signals were
detected in 8 of 8 V/C pigs and in 6 of 8 NV/C pigs. In contrast,
at 5 dpi, IAV antigen was detected in 6 of 8 V/C pigs and in 8 of
8 NV/C pigs. Influenza A virus signals in bronchioles of
Figure 1. Lung, pig No. 112, vaccinated/challenged (V/C) group. Note the multifocal, purple-colored cranioventral and diaphragmatic pulmon-
ary consolidation at 1 day post infection (dpi) in a pig with vaccine-associated enhanced respiratory disease (VAERD). Figure 2. Lung, pig No.
127, vaccinated/challenged (V/C) group. Cranioventral and diaphragmatic consolidation was more widespread affecting an average of 21% of the
lung at 5 day post infection (dpi) in pigs with vaccine-associated enhanced respiratory disease (VAERD). Figure 3. Lung, pig No. 139, non-vac-
cinated/challenged (NV/C) group. Non-vaccinated pigs challenged with pH1N1 demonstrated significantly less pulmonary consolidation com-
pared to Figure 1 at 1 day post infection (dpi) affecting only the cranioventral lung lobes. Figure 4. Lung, pig No. 151, non-vaccinated/
challenged (NV/C) group. Note the significantly lower magnitude of pulmonary consolidation affecting only the cranioventral lung lobes in
non-vaccinated pigs challenged with pH1N1 demonstrated at 5 day post infection (dpi) compared to the vaccine-associated enhanced respira-
tory disease (VAERD)-affected lung in Figure 2.
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Figure 5. Lung, pig No. 135, non-vaccinated/challenged (NV/C) group. Mild bronchiolar epithelial attenuation and suppurative bronchiolitis
(arrow) were observed at 1 day post infection (dpi) with mild alveolar septal thickening and light peribronchiolar cuffing (arrowhead). Hema-
toxylin and eosin, 400. Figure 6. Lung, pig No. 150, non-vaccinated/challenged (NV/C) group. A large bronchiole with epithelial necrosis
(arrow). Note the mild alveolar septal thickening (arrowhead) and light peribronchiolar lymphocytic cuffing at 5 day post infection (dpi). Hema-
toxylin and eosin, 400. Figure 7. Lung, pig No. 110, vaccinated/challenged (V/C) group. Note the acute interlobular and peribronchiolar
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affected lung tissue from both challenge groups consisted of
aggregates of immunoreactive epithelial cells that were attenu-
ated, necrotic, or occasionally morphologically unaffected. In
addition, rare individual immunoreactive cells were identified
in the epithelium of bronchi. Scores for airway epithelial IAV
signals did not differ significantly between the challenge
groups at 1 dpi (data not shown). However, the average score
for airway epithelial signals in the V/C group was significantly
higher (P .01) than the score for the NV/C pigs at 2 dpi. Con-
versely, the average score was significantly higher (P  .05) in
the NV/C pigs at 5 dpi compared to the V/C group.
IAV signals in the alveolar septa or lumen, although present
in both challenge groups, were more widely distributed in the
V/C pigs at 1 and 2 dpi (Fig. 13), in which average IHC scores
specifically for alveolar signals were significantly higher (P 
.05) (data not shown). Similar levels of alveolar septa and
lumen signals were observed in both challenge groups by 5 dpi.
No influenza antigen was detected in either challenge group at
21 dpi or in the NV/NC pigs at any time during the trial. Influ-
enza A virus antigen was identified as cytoplasmic or nuclear
signals in hypertrophic and hyperplastic type II pneumocytes
in the alveolar septum (Fig. 14) or within individual cells con-
fined to the alveolar lumen and interpreted as alveolar macro-
phages or sloughed pneumocytes (Fig. 15).
Trachea Immunohistochemistry
Moderately abundant immunoreactive trachea epithelial cells
contained brown cytoplasmic or nuclear signals observed in
necrotic (Fig. 16) or histopathologically unaffected epithelium.
IAV antigen was not detected in the submucosa. Scores for
IAV signals in trachea were significantly higher in the V/C
pigs at 2 dpi but similar to the NV/C pigs at both 1 and 5 dpi
(data not shown).
Virus Levels in Lung and Nasal Secretions
No IAV was detected in nasal secretions from challenged pigs
in either group at 0 and 1 dpi. At 2 dpi, 7 of 8 V/C pigs and 3 of
8 NV/C pigs were shedding virus. At 3 and 5 dpi, all remaining
pigs challenged with pH1N1 were shedding virus in nasal
secretions. Virus titers from nasal swabs at 2 and 3 dpi were not
significantly different between the V/C and NV/C pigs. In con-
trast, at 5 dpi, titers in swabs from the NV/C pigs were
significantly higher (P  .01) than from V/C pigs (Table 4).
Virus was not being shed in nasal secretions from any chal-
lenged pig remaining at 21 dpi.
Influenza A virus was isolated from the BALF of all chal-
lenged pigs at 1 and 2 dpi and from 8 of 8 NV/C pigs and 4
of 8 V/C pigs at 5 dpi. Virus was not detected in any pigs remain-
ing from either group at 21 dpi. Mean virus titers in the BALF
were significantly higher (P  .05) in the NV/C pigs than in
V/C pigs at 1 and 5 dpi. In contrast, mean BALF virus titers were
significantly higher (P  .0001) in the V/C pigs compared to
NV/C pigs at 2 dpi (Table 4). Virus was not detected at any time
in BALF or nasal swabs in the NV/NC pigs.
Nucleoprotein ELISA, Hemagglutination-Inhibition, and
Serum Neutralization Tests
Pigs in the NV/NC group remained seronegative throughout
the study. Anti-nucleoprotein ELISA (data not shown) and
anti-MN08 HI antibody titers were detected in serum exclu-
sively in the V/C pigs on the day of challenge (0 dpi). The geo-
metric mean reciprocal HI titer was 37.5 (range, 10-160).
Unvaccinated pigs did not demonstrate detectable anti-MN08
HI antibodies. None of the pigs demonstrated detectable anti-
pH1N1 HI antibodies at 0 dpi. Serum neutralization titers
against MN08 virus were only observed in the V/C pigs. The
geometric mean reciprocal titer was 951.0 at 0 dpi (range,
80-5,120). Serum neutralization titers were not observed against
the pH1N1 virus in the V/C, NV/C, or NV/NC groups at 0 dpi.
IgG Antibody Response to Whole Virus MN08 and
pH1N1
Serum anti-MN08 and cross-reacting anti-pH1N1 IgG antibo-
dies were detected in V/C pigs at 0 dpi, the day of challenge
(data not shown). Vaccinated pig serum anti-MN08 and –pH1N1
IgG OD levels were significantly higher (P  .0001) than the
NV/C and NV/NC IgG OD levels. Serum IgG OD levels to
either antigen were not significantly different betweenNV/C and
NV/NC pigs.
Local Anti-Viral and Pro-Inflammatory Cytokine Response
Cytokine concentrations in BALF were evaluated on days 1, 2,
5, and 21 post challenge. At 1 dpi, concentrations of IL-1b, IL-
Figure 7 (continued). edema (arrows) and dilated lymphatics observed in pigs with vaccine-associated enhanced respiratory disease (VAERD)
at 1 day post infection (dpi). Hematoxylin and eosin, 100. Insert: Lung; pig No. 110, V/C group. Marked edema, hemorrhage and neutrophils
(arrow) in alveolar lumina with interlobular edema (asterisk). Hematoxylin and eosin, 200. Figure 8. Lung, pig No. 110, vaccinated/challenged
(V/C) group. Marked suppurative and hemorrhagic bronchiolitis and alveolitis (arrows) were demonstrated by vaccine-associated enhanced
respiratory disease (VAERD)-affected pigs at 1 day post infection (dpi) compared to the NV/C lung displayed in Figure 5. Note the widespread
hemorrhage (arrowheads) and edema (asterisk). Hematoxylin and eosin, 400. Figure 9. Lung, pig No. 115, vaccinated/challenged (V/C) group.
Note the persistent suppurative alveolitis (arrows), hemorrhage, and congestion with type II pneumocyte hypertrophy (arrowhead) demon-
strated at 2 days post infection (dpi). Hematoxylin and eosin, 400. Insert: Lung; pig No. 115, V/C group. Alveoli are dilated with large amounts
of edema (asterisk) at 2 dpi. Hematoxylin and eosin, 400. Figure 10. Lung, pig No. 123, vaccinated/challenged (V/C) group. Note the broad,
dense, peribronchiolar lymphocytic cuffing (double arrow) with marked lymphocyte infiltration of the lamina propria (arrow) and suppurative
bronchiolitis (arrowhead) in pigs with vaccine-associated enhanced respiratory disease (VAERD) at 5 days post infection (dpi) compared to a
NV/C pig displayed in Figure 6. Hematoxylin and eosin, 400.
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Figure 11. Trachea, pig No. 117, vaccinated/challenged (V/C) group. Pigs with vaccine-associated enhanced respiratory disease (VAERD)
demonstrated diffuse necrotizing and lymphocytic tracheitis (arrows). Note the marked, subepithelial lymphocytic infiltration and epithelial
sloughing (asterisk). Hematoxylin and eosin, 400. Figure 12. Lung, pig No. 110, vaccinated/challenged (V/C) group. A bronchiole demonstrat-
ing dark brown nuclear and cytoplasmic signals for influenza A viral antigen in attenuated epithelial cells at 1 day post infection (dpi). Peroxidase
labeled avidin-biotin complex with hematoxylin counterstain, 200. Figure 13. Lung, pig No. 115, vaccinated/challenged (V/C) group. Diffusely
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8, and TNF-a were significantly higher in the V/C pigs
compared to the NV/NC pigs (Figs. 17, 18). This trend contin-
ued on dpi 2, although not all concentrations in V/C pigs were
significantly greater than NV/C or NV/NC pigs. Pigs in the V/C
group had significantly (P < .05) higher concentrations of all
cytokines at 5 dpi compared to NV/C and NV/NC pigs (Figs.
17, 18). At 21 dpi, concentrations of proinflammatory cyto-
kines were considerably lower in all groups compared to dpi
5 and were comparable to dpi 1 concentrations.
Discussion
Vaccine-associated enhanced respiratory disease was demon-
strated in pigs administered a d-cluster inactivated adjuvanted
IAV vaccine followed by challenge with pH1N1, a strain in
which the HA is genetically related to the g-cluster H1 swine
viruses.6,37 Vaccine-associated enhanced respiratory disease
is a reproducible phenomenon characterized by an acute onset
of severe respiratory disease reported previously in studies with
vaccinated and challenged cross-bred pigs.8,12,16,38 However,
to further understand the pathogenesis and elucidate potential
mechanisms associated with VAERD, it was necessary to eval-
uate the development of macroscopic and microscopic lung
lesions at multiple times during the acute post-challenge phase
of the inflammatory response.
Microscopically, uncomplicated influenza infection in
swine affects the intrapulmonary epithelium causing a necro-
tizing bronchiolitis.9,10 During the acute phase of infection, a
transient neutrophil response to the epithelial necrosis is
replaced by peribronchiolar and interstitial lymphocytes simi-
lar to what we describe in the NV/C pigs in this report.23,29,34,46
However, V/C pigs demonstrated more severe microscopic
lesions in sharp contrast to the NV/C group that we interpret
as features exclusive to VAERD. Widespread interlobular and
alveolar edema with marked hemorrhage were observed as
early as 1 dpi, suggesting VAERD is an acute inflammatory
reaction associated with the immune response to the vaccine
(Figs. 7, 8). Interlobular edema and hemorrhage have been pre-
viously described for other porcine respiratory viruses such as
PCV27and PRRSV.11 To our knowledge, the enhanced pulmon-
ary lesions we observed in VAERD-affected pigs are unique
compared to lesions associated with acute influenza virus infec-
tion described previously in naı¨ve pigs34 and may be a compo-
nent of the pathogenesis of VAERD. In addition, a marked
suppurative inflammatory response in the V/C pigs extended
beyond affected bronchi and bronchioles to include widespread
regions of the alveoli in affected lobules at 1 dpi (Fig. 7). The
hemorrhage and edema persisted at 2 dpi in the V/C group with
a persistent neutrophil response that had subsided as expected in
the NV/C pigs, suggesting another difference between VAERD-
affected and non-vaccinated/challenged pigs (Fig. 9). It is
unknown whether the elevated lung consolidation in the V/C
pigs may have been elicited by the abundant neutrophil response
in both intrapulmonary airways and alveoli, although they have
been implicated as contributors to the clinicopathologic effects
of influenza virus infection.17,33
At 2 and 5 dpi, microscopic lung lesions continued to
increase in severity in the V/C pigs and correlated with the ele-
vated macroscopic lung consolidation (Fig. 2). Widespread
alveolar septal thickening was characterized by intense lym-
phocyte and macrophage infiltration of alveolar septa and
lumina, prominent type II pneumocyte hypertrophy and
Figure 13 (continued). scattered interstitial influenza A signals were detected in alveolar septa or lumina at elevated levels in pigs with
vaccine-associated enhanced respiratory disease (VAERD) at 1 and 2 days post infection (dpi). A necrotic bronchiole exhibits influenza A signals
in epithelium (arrowhead). Peroxidase labeled avidin-biotin complex with hematoxylin counterstain, 200. Figure 14. Lung, pig No. 106,
vaccinated/challenged (V/C) group. Note the nuclear and cytoplasmic influenza A viral antigen signals in alveolar type II hypertrophic and hyper-
plastic pneumocytes (arrows) in pigs with vaccine-associated enhanced respiratory disease (VAERD) at 1 day post infection (dpi). Peroxidase
labeled avidin-biotin complex with hematoxylin counterstain, 400. Figure 15. Lung, pig No. 115, vaccinated/challenged (V/C) group. Nuclear
influenza A viral antigen signals were detected in cells interpreted as macrophages or sloughed pneumocytes (arrows) located in alveolar lumina
among neutrophils and cellular debris in V/C pigs at 2 days post infection (dpi). Peroxidase labeled avidin-biotin complex with hematoxylin coun-
terstain, 600. Figure 16. Trachea, pig No. 113, vaccinated/challenged (V/C) group. A trachea with influenza A viral antigen signals within atte-
nuated or necrotic epithelium (arrows). Peroxidase labeled avidin-biotin complex with hematoxylin counterstain, 100. Insert: Trachea; pig No.
113, V/C group. Note the nuclear influenza A viral antigen signals in necrotic epithelium (arrowhead). Peroxidase labeled avidin-biotin complex
with hematoxylin counterstain, 400.
Table 4. Comparison of pH1N1 Virus Titers in Bronchoalveolar Lavage Fluid (BALF) and Nasal Swabs in Vaccinated/Challenged (V/C), Non-
Vaccinated/Challenged (NV/C), and Non-Vaccinated/Non-Challenged (NV/NC) Pigs at 1, 2, and 5 Days After pH1N1 Inoculation (dpi; Data
Presented as the Mean Virus Titer + Standard Error of the Mean)
Group
Virus titersx (BALF) Virus titersx (nasal swabs)
1 dpi 2 dpi 5 dpi 2 dpi 3 dpi 5 dpi
V/C 4.5 + 0.3a
y 4.8 + 0.2a 1.4 + 0.6a 2.5 + 0.5a 3.4 + 0.2a 2.4 + 0.2a
NV/C 6.1 + 0.3b 3.7 + 0.1b 4.2 + 0.3b 1.6 + 0.7a 3.5 + 0.4a 3.2 + 0.1b
NV/NC 0.0 + 0.0c 0.0 + 0.0c 0.0 + 0.0c 0.0 + 0.0b 0.0 + 0.0b 0.0 + 0.0c
xVirus titers represented as log10 /ml of BALF or nasal swab solution.
yDifferent superscripts (a, b, c) indicate significantly different (P  .05) mean virus titers (log10 /ml) within a column for each dpi.
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hyperplasia, and variable numbers of neutrophils (Fig. 9).
Additional lesions characteristic of VAERD included thick
peribronchiolar lymphocytic cuffs and marked infiltration of
lymphocytes in the bronchiolar lamina propria (Fig. 10). The
pronounced lymphocyte inflammatory response in the lung
appears to be a consistent lesion associated with VAERD in
swine. Our data also suggest the trachea undergoes an
enhanced lymphocytic inflammatory response similar to the
lungs representing another component of VAERD. Interest-
ingly, V/C and NV/C pigs demonstrated similar levels of
necrotizing bronchitis and bronchiolitis throughout the study,
reflecting the effects of influenza virus replication in respiratory
epithelium. This is consistent with the lack of cross-protective
vaccine immunity observed in the V/C pigs. However, viral
titers in BALF or nasal swabs were not correlated with enhanced
lesions demonstrated in the V/C pigs as the acute, post-
inoculation period progressed and elevated viral replication does
not explain the pathogenesis of VAERD.
Pro-inflammatory cytokines play an important role in the
pathogenesis of influenza infection in swine and have been cor-
related with viral replication and clinical signs35 as well as
increased lung lesions and neutrophil infiltration.34 In this report,
TNF-a, IL-1b, IL-6, and IL-8 BALF concentrations were ele-
vated in the V/C pigs compared to the NV/C pigs. A similar
pro-inflammatory cytokine response was previously described
by our group,8 suggesting elevated pro-inflammatory cytokines
may be characteristic of VAERD and contribute to the develop-
ment of acute lesions observed in the V/C pigs. Elevated IL-8, a
neutrophil chemotactic cytokine, may have contributed to
the prominent and prolonged suppurative response in alveoli,
bronchi, and bronchioles in V/C pigs. In addition, previous
reports have shown a positive correlation between elevated
TNF-a and IL-1b with neutrophil recruitment to the lungs, sug-
gesting both cytokines may have been involved in the neutrophil
response described in this report.34 A specific mechanism, such
as Fc-receptor or complement mediated activation, may have
contributed to the exaggerated cytokine response detected in
the V/C pigs. Mechanisms associated with VAERD remain
unknown but under investigation at this time.
VAERD in swine has been reproduced under experimental
conditions although it may remain undiagnosed in field situa-
tions where mixed viral and bacterial respiratory infections
are common. However, an antigenically diverse population of
IAVs combined with increased IAV vaccine usage in swine
creates optimal conditions for vaccine-virus mismatch and
potential VAERD. Seronegative children or mice administered
an inactivated RSV vaccine followed by exposure to wild type
RSV demonstrated enhanced respiratory disease similar to
what we describe for VAERD in swine.4,14,27 Preexisting vac-
cine antibodies may enhance other viral infections in humans.
Atypical measles resulted from the use of formalin-inactivated
vaccines administered to infants and children who later devel-
oped severe forms of the disease when exposed to wild type
virus, suggesting a similar mechanism to enhanced disease
associated with vaccine immunity to RSV.5
Our data suggest VAERD results from a multifactorial
mechanism that includes cross-reactive antibodies (IgG isotype)
to conserved or non-neutralizing epitopes elicited by inactivated
vaccines in the absence of HI or neutralizing antibodies. Non-
neutralizing antibodies induced by the vaccine may play a role
in antibody dependent cell-mediated cytotoxicity or antibody
dependent enhancement. Antibodies involved in antigen-
antibody complexes or complement fixation may have also con-
tributed to the clinical disease and lung lesions we observed in
this study. A previous study in vaccinated swine described an
association between non-neutralizing M2 antibodies and an
Figure 17.Cytokine IL-1b and IL-8 protein concentrations in bronch-
oalveolar lavage fluid (BALF) from vaccinated/challenged (V/C), non-
vaccinated/challenged (NV/C), and non-vaccinated/non-challenged
(NV/NC) pigs at 1, 2, 5, and 21 days after pH1N1 inoculation. Data
presented as box plots demonstrating the median cytokine concentra-
tion (pg/ml), 5th and 95th percentile and standard deviation per group.
Connecting horizontal lines are significantly different (P < .05).
Figure 18. Cytokine IL-6 and TNF-a protein concentration in bronch-
oalveolar lavage fluid (BALF) of vaccinated/challenged (V/C), non-vacci-
nated/challenged (NV/C), and non-vaccinated/non-challenged (NV/NC)
pigs at 1, 2, 5, and 21 days after pH1N1 inoculation. Data presented as
box plots demonstrating the median cytokine concentration (pg/ml) per
group with the 5th and 95th percentile and standard deviation. Con-
necting horizontal lines are significantly different (P < .05).
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NP-specific lymphoproliferative response with enhanced
clinical disease.12 The data suggested the cellular immune
response (lymphocytes), in addition to antibodies, may have
contributed to disease enhancement. The V/C pigs in the current
study also demonstrated an NP antibody response to the inacti-
vated vaccine, although the role for NP-induced antibodies or
cellular responses in VAERD requires further characterization.
A recent epidemiological report from Canada described an
association between prior immunization with the 2008-2009 tri-
valent inactivated seasonal influenza vaccine and an increased
risk of medically attended pH1N1 illness in humans.31 Although
differences exist in the conditions involved in the human and
swine diseases, data from human subjects suggest mechanisms
that may correspond to VAERD in swine.22 A recent report
described a correlation between severe pandemic 2009 H1N1
respiratory disease in middle-aged adults and the presence of
preexisting serum antibodies that cross-reacted with the virus but
did not confer protection.22 The report described the presence of
pulmonary immune complexes consisting of low avidity antibo-
dies to the 2009 pH1N1 antigen in association with high levels of
activated complement in people with severe respiratory disease.
A detailed description of potential VAERD mechanisms is
beyond the scope of this report; however, studies are in progress
to determine the pathogenesis of VAERD in swine.
In summary, this report demonstrates an enhanced disease
process in vaccinated pigs challenged with a heterologous
influenza A virus resulting in more severe macroscopic and
microscopic lung lesions compared to pigs that did not receive
prior vaccination but challenged with the same virus. Cross-
reactive antibodies that lack neutralizing capabilities but have
the ability to activate complement may play an initiating role
in the process since features of the phenomenon occur very
rapidly, as early as 1 dpi. However, multiple contributing fac-
tors, including dysregulation of proinflammatory cytokines
and the various immune cell types identified in the cellular
infiltrates in VAERD-affected lungs, need further investigat-
ing to determine the cause of the immunopathology associated
with VAERD in swine.
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